Crinetics Pharmaceuticals Inc (CRNX)
Stock-Based Compensation
$98.98M
TTM · Period ending: · USD
CRNX Stock-Based Compensation
Latest reported$98.98Mperiod ending
Latest reported$98.98Mperiod ending
CRNX TTM Stock-Based Comp ($271.00K → $98.98M)
TTM stock-based compensation
High-resolution chart · PNG
CRNX stock-based compensation history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 98,983,000 | |
| 100,226,000 | |
| 91,024,000 | |
| 88,149,000 | |
| 83,594,000 | |
| 76,410,000 | |
| 69,386,000 | |
| 62,158,000 | |
| 55,060,000 | |
| 46,295,000 | |
| 32,841,000 | |
| 21,224,000 | |
| 17,609,000 | |
| 7,434,000 | |
| 7,434,000 | |
| 12,592,000 | |
| 9,713,000 | |
| 13,946,000 | |
| 17,352,000 | |
| 12,194,000 | |
| 10,420,000 | |
| 8,715,000 | |
| 7,456,000 | |
| 7,456,000 | |
| 6,529,000 | |
| 5,582,000 | |
| 4,463,000 | |
| 5,310,000 | |
| 4,231,000 | |
| 2,922,000 | |
| 2,320,000 | |
| 1,545,000 | |
| 841,000 | |
| 641,000 | |
| 271,000 |